Nuvilex, Inc., Johnson & Johnson, and Medtronic, Inc., All Developing Type of Artificial Pancreas for Diabetics

Nuvilex, Inc., Johnson & Johnson, and Medtronic, Inc., All Developing Type of 
Artificial Pancreas for Diabetics 
NEW YORK, NY -- (Marketwired) -- 07/02/13 --  While Medtronic, Inc.
and Johnson & Johnson are developing devices that can essentially act
as a type of "artificial pancreas," Nuvilex, Inc.'s (OTCQB: NVLX)
unique cell encapsulation technology has shown it too can develop a
type of "artificial pancreas" in preclinical diabetes studies. Their
approaches couldn't be more different; however, all three companies
are convinced that developing an artificial pancreas offers diabetics
the best solution to independently monitor their blood sugar levels,
and in turn, provide them with insulin when needed. 
At the end of June, both Medtronic and Johnson & Johnson presented
results from separate studies using their medical insulin pumps at
the American Diabetes Association meeting in Chicago. The idea behind
the "smart" pumps is to mimic a healthy pancreas by offering
diabetics a type of artificial pancreas that can successfully monitor
changes in blood sugar levels and then adjust the insulin being
delivered to the diabetic in response to those changes.  
As the two NYSE-traded companies turn to medical devices to act as
their brand of artificial pancreas, the small, Silver Spring,
Maryland-based biotech, Nuvilex, is turning to a much smaller and
different option -- transplanted living, insulin-producing cells
enclosed in capsules about the size of the head of a pin, that form a
bundle and act as a miniature cell factory that produces insulin upon
demand inside the diabetic's body. 
According to the International Diabetes Federation, 371 million
people around the world have been diagnosed with diabetes and another
187 million remain undiagnosed. As the number of diagnosed diabetics
around the world grows, so too does the market for a solution. By
2020, the market for diabetes medicines and treatments is projected
to reach $65 billion worldwide. 
Continue reading this article at 
About Stock Market Media Group 
Stock Market Media Group is a full service Investment Relations firm
specializing in Research and Content Development. It offers a
platform for CEOs to tell their story through the media with Research
Reports, CEO Interviews and Feature Articles while building a library
of Research for Investors to become better informed on small cap
companies. For more information:  
Stock Market Media Group
(646) 397-4020 
Press spacebar to pause and continue. Press esc to stop.